EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence

Margarida Manso iD, João Diogo Soares, Margarida Henriques, Francisco Botelho iD, Carlos Silva, Francisco Cruz iD

Toxins · 2024

DOI: 10.3390/toxins16080332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2024. Verfasst von Margarida Manso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, Centro Hospitalar Universitário São João, 4200-319 Porto, Portugal. Hauptthemen laut MEDLINE: Urinary Incontinence, Urge, Patient Satisfaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urgency urinary incontinence (UUI) refractory to medical treatment poses significant challenges despite advancements. This study evaluates the efficacy of intravesical botulinum toxin for UUI and identifies factors influencing treatment outcomes. Among 368 women receiving botulinum toxin injections, 74.5% achieved a complete discontinuation of pad usage. Predictors of efficacy included lower pre-treatment pad usage and the absence of prior sling placement. Patients often required repeat injections (60.3%), with younger age and satisfaction correlating with treatment repetition. The interval between injections averaged 18 months, influenced by logistical challenges and patient preferences. Despite concerns about diminishing efficacy, subjective perceptions did not align with objective findings. Limitations include retrospective analysis and heterogeneous clinical records. In conclusion, intravesical botulinum toxin is effective for UUI, with pre-treatment pad usage and sling placement history influencing outcomes and patient characteristics influencing treatment repetition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Incontinence, UrgePatient SatisfactionHumansFemaleMiddle AgedRetrospective StudiesAgedTreatment OutcomeAdministration, IntravesicalBotulinum Toxins, Type AAdultBotulinum ToxinsAged, 80 and overPatient Compliance

Stichwörter der Autor:innen

Botox®bladder botulinum toxinfemale urinary incontinenceoveractive bladderurgency urinary incontinence

Substanzen

Botulinum Toxins, Type ABotulinum Toxins

Autor:innen und Institutionen

  • Urology Department, Centro Hospitalar Universitário São João, 4200-319 Porto, Portugal.
  • Faculdade de Medicina da Universidade do Porto, 4200-319 Porto, Portugal.
  • Instituto de Investigação em Ciências da Vida e Saúde, Escola de Medicina da Universidade do Minho, 4710-057 Braga, Portugal.

ORCID-Profile: Margarida Manso, Francisco Botelho, Francisco Cruz

Zitieren

APA

Manso, M., Soares, J. D., Henriques, M., Botelho, F., Silva, C., & Cruz, F. (2024). Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence. Toxins. https://doi.org/10.3390/toxins16080332

Vancouver

Manso M, Soares JD, Henriques M, Botelho F, Silva C, Cruz F. Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence. Toxins. 2024. doi:10.3390/toxins16080332

BibTeX
@article{Manso2024,
  author = {Manso, Margarida and Soares, João Diogo and Henriques, Margarida and Botelho, Francisco and Silva, Carlos and Cruz, Francisco},
  title = {Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16080332}
}
Kostenlos starten →